SS
APGE

Sunbelt Securities’s Apogee Therapeutics APGE Stock Holding History

Sunbelt Securities’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$253 Hold
3
– – ﹤0.01% 2460
2025
Q4 		$226 Hold
3
– – ﹤0.01% 2411
2025
Q3 		$119 Buy
+3
New +$115 ﹤0.01% 2489

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Sunbelt Securities's APGE Position: Q1 2026 in Review

Sunbelt Securities held its Apogee Therapeutics (APGE) position steady in Q1 2026 at 3 shares worth $253. The position accounts for ﹤0.01% of the portfolio, ranked #2460.

Sunbelt Securities first reported a position in APGE in Q3 2025 and has held it in 3 quarters since. 224 funds tracked by Wall St. Rank hold APGE as of Q1 2026.

  • Sunbelt Securities held 3 shares of Apogee Therapeutics worth $253 as of Q1 2026.
  • Sunbelt Securities left its Apogee Therapeutics share count unchanged in Q1 2026.
  • Apogee Therapeutics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2460 holding.
  • Sunbelt Securities first reported a position in Apogee Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 224 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.